
New U.S. Drug Tariffs Spark Global Health Equity Concerns
Experts warn proposed U.S. tariffs on pharmaceuticals could raise drug prices, strain supply chains, and undermine global health equity, impacting low-income populations.
News & Insights Across Asia
Experts warn proposed U.S. tariffs on pharmaceuticals could raise drug prices, strain supply chains, and undermine global health equity, impacting low-income populations.
China’s pharmaceutical trade association opposes US tariffs, citing threats to global healthcare access and pharmaceutical industry stability.
America faces a deepening addiction crisis fueled by aggressive pharmaceutical marketing and over-prescription of pills, highlighting the urgent need for systemic reforms.